4-Fluoro safinamide(202825-43-2)
- Name: 4-Fluoro safinamide
- Synonyms:4-Fluoro safinamide;FE4YUP8N4D;UNII-FE4YUP8N4D;202825-43-2;Propanamide, 2-(((4-((4-fluorophenyl)methoxy)phenyl)methyl)amino)-, (2S)-;SCHEMBL2016084;(S)-2-[[4-(4-Fluorobenzyloxy)benzyl]amino]propanamide
- Molecular Formula:C17H19FN2O2
- Molecular Weight:302.34
- CAS Registry Number:202825-43-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.202825-43-2 (S)-2-((4-((4-fluorobenzyl)oxy)benzyl)amino)propanamide
Assay:NLT 98% Appearance:White powder Package:Aluminum bag Storage:Room temperature Transportation:By air Application:Used in producing API
Min. Order:0
Supplier:Hangzhou Huarong Pharm Co., Ltd. [
China (Mainland)]
CAS No.202825-43-2 Safinamide Impurity 2
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
CAS No.202825-43-2 4-Fluoro safinamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-Fluoro safinamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.202825-43-2 Safinamide Impurity 2 CAS No.202825-43-2
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]
CAS No.202825-43-2 (S)-2-((4-((4-fluorobenzyl)oxy)benzyl)amino)propanamide
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 1050381-35-5/(R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide
- 1185303-70-1/4-[(4-Methylphenoxy)methyl]piperidine hydrochloride
- 1159822-29-3/2-(Pyrimidin-2-yloxy)benzonitrile
- 956034-45-0/Methanesulfonamide, N-methyl-N-(2-pyrrolidinylmethyl)-
- 893639-92-4/Ethyl 5-(morpholinomethyl)isoxazole-3-carboxylate
- 1314785-90-4/1-(4-Bromo-3-fluorophenyl)cyclobutanamine
- 890095-59-7/5-(chloromethyl)-3-phenylpyrazolo[1,5-a]pyrimidin-7(4H)-one
- 1160256-30-3/2-(4-Butylphenyl)-7-chloro-8-methylquinoline-4-carbonyl chloride
- 1774898-55-3/tert-Butyl 4-(4-nitropyridin-3-yl)piperazine-1-carboxylate
- 1219961-34-8/3-Azetidinyl 4-(1-methyl-1-phenylethyl)phenyl ether
- 1331910-75-8/Valacyclovir-d4, Hydrochloride
- 1188265-25-9/3-Fluoro-2-hydrazinyl-5-(trifluoromethyl)pyridine
- 898782-24-6/3-(3-Bromophenyl)-4'-carboethoxypropiophenone
- 17792-04-0/6,6-Dimethyl-4-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydrobenzo[c]chromen-3-ol;hydrochloride
- 1860028-18-7/6-Fluoro-5-nitro-2,3-dihydro-1H-indole
- 1310746-11-2/Infigratinib monohydrate
- 1385694-48-3/1-(2-Methoxyphenyl)-4-oxocyclohexanecarboxylic Acid
- 902836-70-8/1-(2-(2,4-Difluorophenoxy)-5-fluorophenyl)-N-methylmethanamine
- 1017791-15-9/N-(1H-Indol-6-ylmethyl)cyclopentanamine
- 202825-43-2/4-Fluoro safinamide
- 1092460-52-0/Tert-butyl 4-chloro-2-hydroxybenzoate
- 28241-31-8/4-(3,6-Dimethoxynaphthalen-2-yl)-4-oxobutanoic acid
- 1030849-63-8/Rizatriptan N,N,N-Trimethylethanammonium Chloride
- 1236263-42-5/N-Cyclohexyl-N-ethyl-2-piperidinecarboxamide hydrochloride
- 1019461-43-8/2-(2-Methyl-1-piperidinyl)nicotinic acid
- 1374652-61-5/3-Chloro-N-methylisoquinolin-5-amine
- 1263358-13-9/3-Dechloro-3-bromo trazodone
- 1796928-63-6/7-[4-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]butoxy]-3,4-dihydro-1H-quinolin-2-one
- 1346447-09-3/6-iodo-3,4-dihydro-2H-pyrano[3,2-b]pyridine-8-carbonitrile
- 943975-33-5/Methyl 2-bromo-4-chloro-6-fluorobenzoate